Search research articles
Contact Us
Filters
Showing results (101-110 of 155) with videos related to
Page
of 16
Sort By:
Journal of Proteome Research
|
November 11, 2009
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells
Carol L Nilsson, Roslyn Dillon, Arugadoss Devakumar, et al.
Cancer
|
August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
J Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Neuro-Oncology
|
October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski, Howard Colman, John F De Groot, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 18, 2021
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
Trang H Au, Connor Willis, Maija Reblin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 12, 2021
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
Trang H Au, Connor Willis, Maija Reblin, et al.
Nature Communications
|
November 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors
Xuefeng Wang, Tingyi Li, Islam Eljilany, et al.
Neuro-Oncology
|
March 14, 2020
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma
Vinay K Puduvalli, Jing Wu, Ying Yuan, et al.
Acta Neuropathologica
|
January 31, 2020
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Genes & Development
|
December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Krishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 155) with videos related to
Sort By:
Page
of 16
Journal of Proteome Research
|
November 11, 2009
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells
Carol L Nilsson, Roslyn Dillon, Arugadoss Devakumar, et al.
Cancer
|
August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
J Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Neuro-Oncology
|
October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski, Howard Colman, John F De Groot, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 18, 2021
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
Trang H Au, Connor Willis, Maija Reblin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 12, 2021
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
Trang H Au, Connor Willis, Maija Reblin, et al.
Nature Communications
|
November 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors
Xuefeng Wang, Tingyi Li, Islam Eljilany, et al.
Neuro-Oncology
|
March 14, 2020
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma
Vinay K Puduvalli, Jing Wu, Ying Yuan, et al.
Acta Neuropathologica
|
January 31, 2020
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Genes & Development
|
December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Krishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Page
of 16